A randomized assessor-blinded comparison of low-irradiance and conventional-irradiance photodynamic therapy for superficial basal cell carcinoma and Bowen disease

Sally H. Ibbotson; James Ferguson; Harry Moseley; Ifor D. W. Samuel; Andrea E. Lesar; Robert S. Dawe

doi:10.1111/bjd.20762

A randomized assessor-blinded comparison of low-irradiance and conventional-irradiance photodynamic therapy for superficial basal cell carcinoma and Bowen disease

Sally H. Ibbotson (Lead / Corresponding author), James Ferguson, Harry Moseley, Ifor D. W. Samuel, Andrea E. Lesar, Robert S. Dawe

Undergraduate Medicine

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

157 Downloads (Pure)

Abstract

The inconvenience and pain of hospital-based photodynamic therapy (PDT) is sometimes limiting.1 We developed very low irradiance LEDs for ambulatory PDT. Preliminary studies showed this to be convenient and relatively painless.1-4 Here we evaluate the Ambulight® device (Ambicare Health Ltd) in a randomised controlled assessor-blinded study comparing low irradiance ambulatory PDT (APDT) with conventional PDT (CPDT) for superficial basal cell carcinoma (SBCC) and Bowen’s disease (BD) (lesions ≤2cm).

Original language	English
Pages (from-to)	577-579
Number of pages	3
Journal	British Journal of Dermatology
Volume	186
Issue number	3
Early online date	21 Sept 2021
DOIs	https://doi.org/10.1111/bjd.20762
Publication status	Published - 7 Mar 2022

ASJC Scopus subject areas

Dermatology

Access to Document

10.1111/bjd.20762

Author Accepted ManuscriptAccepted author manuscript, 2.29 MB

Cite this

@article{5d1489885d764518ad867c20d69d722d,

title = "A randomized assessor-blinded comparison of low-irradiance and conventional-irradiance photodynamic therapy for superficial basal cell carcinoma and Bowen disease",

abstract = "The inconvenience and pain of hospital-based photodynamic therapy (PDT) is sometimes limiting.1 We developed very low irradiance LEDs for ambulatory PDT. Preliminary studies showed this to be convenient and relatively painless.1-4 Here we evaluate the Ambulight{\textregistered} device (Ambicare Health Ltd) in a randomised controlled assessor-blinded study comparing low irradiance ambulatory PDT (APDT) with conventional PDT (CPDT) for superficial basal cell carcinoma (SBCC) and Bowen{\textquoteright}s disease (BD) (lesions ≤2cm).",

author = "Ibbotson, {Sally H.} and James Ferguson and Harry Moseley and Samuel, {Ifor D. W.} and Lesar, {Andrea E.} and Dawe, {Robert S.}",

note = "{\textcopyright} 2021 British Association of Dermatologists",

year = "2022",

month = mar,

day = "7",

doi = "10.1111/bjd.20762",

language = "English",

volume = "186",

pages = "577--579",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Oxford University Press",

number = "3",

}

A randomized assessor-blinded comparison of low-irradiance and conventional-irradiance photodynamic therapy for superficial basal cell carcinoma and Bowen disease. / Ibbotson, Sally H. (Lead / Corresponding author); Ferguson, James; Moseley, Harry et al.
In: British Journal of Dermatology, Vol. 186, No. 3, 07.03.2022, p. 577-579.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - A randomized assessor-blinded comparison of low-irradiance and conventional-irradiance photodynamic therapy for superficial basal cell carcinoma and Bowen disease

AU - Ibbotson, Sally H.

AU - Ferguson, James

AU - Moseley, Harry

AU - Samuel, Ifor D. W.

AU - Lesar, Andrea E.

AU - Dawe, Robert S.

PY - 2022/3/7

Y1 - 2022/3/7

N2 - The inconvenience and pain of hospital-based photodynamic therapy (PDT) is sometimes limiting.1 We developed very low irradiance LEDs for ambulatory PDT. Preliminary studies showed this to be convenient and relatively painless.1-4 Here we evaluate the Ambulight® device (Ambicare Health Ltd) in a randomised controlled assessor-blinded study comparing low irradiance ambulatory PDT (APDT) with conventional PDT (CPDT) for superficial basal cell carcinoma (SBCC) and Bowen’s disease (BD) (lesions ≤2cm).

AB - The inconvenience and pain of hospital-based photodynamic therapy (PDT) is sometimes limiting.1 We developed very low irradiance LEDs for ambulatory PDT. Preliminary studies showed this to be convenient and relatively painless.1-4 Here we evaluate the Ambulight® device (Ambicare Health Ltd) in a randomised controlled assessor-blinded study comparing low irradiance ambulatory PDT (APDT) with conventional PDT (CPDT) for superficial basal cell carcinoma (SBCC) and Bowen’s disease (BD) (lesions ≤2cm).

UR - http://www.scopus.com/inward/record.url?scp=85119672864&partnerID=8YFLogxK

U2 - 10.1111/bjd.20762

DO - 10.1111/bjd.20762

M3 - Letter

C2 - 34545565

SN - 0007-0963

VL - 186

SP - 577

EP - 579

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 3

ER -

A randomized assessor-blinded comparison of low-irradiance and conventional-irradiance photodynamic therapy for superficial basal cell carcinoma and Bowen disease

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this